Purchases and Sales Made in Q1 2024 in Akoya Biosciences, Inc. (AKYA)
This table provides information about the institutional ownership of Akoya Biosciences, Inc. (AKYA) during Q1 2024. The information is specifically focused on institutions that hold shares of Akoya Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q1 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-27.5K- 92.12% |
$119K - $167K
|
2.36K
$5.09K
|
|
|
May 08, 2024
Q1 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-33.1K- 16.15% |
$143K - $200K
|
172K
$371K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-44.4K- 41.06% |
$192K - $269K
|
63.8K
$138K
|
|
|
May 03, 2024
Q1 2024
|
Peddock Capital Advisors, LLC
|
SELL
|
- |
-50.7K- 17.43% |
$219K - $307K
|
240K
$519K
|
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-107K- 67.96% |
$463K - $648K
|
50.4K
$109K
|